Alternative methods to reduce allergy include modifying the antigenicity of the L-asparaginase protein, or even deriving L-asp through other bacteria [44], although the cost and availability in LMICs where the impact is greatest need to be considered accordingly. The gene discussed is ASPG; the disease is allergic disease.